The House resumed from March 3 consideration of Bill C-393, An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act, as reported (with amendment) from the committee, and of the amendment to Motion No. 3.
In the House of Commons on March 9th, 2011. See this statement in context.